This systematic review analyzed cancer-specific questions across 316 completed Demographic and Health Surveys in 90 low- and middle-income countries.
PLOS Global Public Health · 5 authors, 4 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This systematic review analyzed cancer-specific questions across 316 completed Demographic and Health Surveys in 90 low- and middle-income countries.
This systematic review examined all Demographic and Health Surveys (DHS) conducted since 1985 to assess the inclusion of cancer-specific questions in population-based surveys across low- and middle-income countries. Of 316 completed surveys across 90 countries, 81 (25.6%) included at least one cancer-specific question. Cervical cancer questions appeared in 54 surveys (17.1%), breast cancer in 41 (13.0%), prostate cancer in 8 (2.5%), and other cancers in 40 (12.6%). Only 39 of 90 countries (43.3%) had at least one survey with cancer-specific questions. The frequency of cancer questions increased over time from approximately 15% in 1985–1989 to 60% in 2020–2021. The Latin America and Caribbean region had the most surveys with cancer questions, while Africa had the fewest relative to its total number of DHS surveys. Limitations include that the review did not assess broader DHS methodology such as training manuals, question conceptualization, or use of data in practice.